YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY – Get Free Report)’s share price traded down 2.7% during mid-day trading on Monday . The company traded as low as $15.82 and last traded at $15.98. 180,616 shares traded hands during trading, a decline of 15% from the average daily volume of 211,406 shares. The stock had previously closed at $16.42.
YieldMax MRNA Option Income Strategy ETF Stock Performance
The company’s 50-day simple moving average is $17.07 and its 200 day simple moving average is $17.95.
YieldMax MRNA Option Income Strategy ETF Company Profile
The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.
See Also
- Five stocks we like better than YieldMax MRNA Option Income Strategy ETF
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for YieldMax MRNA Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YieldMax MRNA Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.
